$0.7500
-0.09-10.71%
Pre-Market: 7:06 AM EDT
Comments
Loading...
Cyclo Therapeutics (NASDAQ:CYTH) Stock, Earnings Estimates, EPS, And Revenue
Cyclo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 17
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$322.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$870.73K
Analyze the earnings history of Cyclo Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Cyclo Therapeutics (CYTH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.31 | $-0.16 | -93.8 % |
| Q2 | 2024-08-14 | $-0.21 | $-0.15 | -40.0 % |
| Q2 | 2023-08-14 | $-0.33 | $-0.44 | 25.0 % |
| Q1 | 2023-05-15 | $-0.46 | $-0.42 | -9.52 % |
Cyclo Therapeutics (CYTH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $233.77K | $294.00K | -20.5 % |
| Q2 | 2024-08-14 | $123.10K | $270.00K | -54.4 % |
| Q3 | 2023-11-14 | $459.48K | $430.00K | 6.86 % |
| Q2 | 2023-08-14 | $117.12K | $400.00K | -70.7 % |
FAQ
When is Cyclo Therapeutics (NASDAQ:CYTH) reporting earnings?
Cyclo Therapeutics (CYTH) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Cyclo Therapeutics (NASDAQ:CYTH)?
The Actual EPS was $-0.31, which missed the estimate of $-0.16.
What were Cyclo Therapeutics’s (NASDAQ:CYTH) revenues?
The Actual Revenue was $233.8K, which missed the estimate of $294K.
Browse earnings estimates, EPS, and revenue on all stocks.